RNA5SP390: A Potential Drug Target and Biomarker (G100873643)
RNA5SP390: A Potential Drug Target and Biomarker
RNA5SP390 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the cell鈥檚 transcriptional machinery, playing a critical role in the regulation of gene expression and cell growth. The identification of RNA5SP390 as a potential drug target has significant implications for the development of new therapeutic approaches for a variety of diseases.
The Discovery of RNA5SP390
RNA5SP390 was first identified using RNA sequencing technology. The RNA sequencing data showed that RNA5SP390 was expressed in a wide range of tissues and cells, including brain, heart, and cancer cells. It was also found to be highly expressed in tissues that are often affected by diseases, such as cancer and neurodegenerative disorders.
The Function of RNA5SP390
RNA5SP390 is a key regulator of the cell鈥檚 transcriptional machinery. It interacts with the protein RNA polymerase II (RNA polymerase II), which is responsible for transcribing DNA into RNA. RNA5SP390 functions as a negative regulator of RNA polymerase II, by binding to a specific site on the enzyme and inhibiting its activity. This interaction between RNA5SP390 and RNA polymerase II makes it a potential drug target.
RNA5SP390 is involved in the regulation of a wide range of gene expression, including cell growth, differentiation, and survival. It has been shown to regulate the expression of genes involved in cell adhesion, migration, and invasion, as well as genes involved in cell survival and apoptosis. RNA5SP390 has also been shown to play a role in the regulation of cell cycle progression, and is involved in the regulation of mitosis and meiosis.
The Potential Role of RNA5SP390 as a Drug Target
The potential drug target for RNA5SP390 is based on its role as a negative regulator of RNA polymerase II. By inhibiting the activity of RNA polymerase II, RNA5SP390 has been shown to have a negative impact on gene expression and cell growth. This makes RNA5SP390 an attractive target for small molecule inhibitors, which can be used to treat diseases that are characterized by hyperactive gene expression, such as cancer and neurodegenerative disorders.
RNA5SP390 has been shown to play a role in the regulation of a wide range of cellular processes, including cell growth, differentiation, and apoptosis. It has been shown to regulate genes involved in cell adhesion, migration, and invasion, as well as genes involved in cell survival and apoptosis. This makes RNA5SP390 an attractive target for small molecule inhibitors, which can be used to treat diseases that are characterized by hyperactive gene expression, such as cancer and neurodegenerative disorders.
RNA5SP390 has also been shown to play a role in the regulation of cell cycle progression, and is involved in the regulation of mitosis and meiosis. This suggests that RNA5SP390 may also be a useful target for drugs that are aimed at treating conditions that are characterized by changes in the cell鈥檚 circadian rhythms, such as cancer and neurodegenerative disorders.
The Potential Role of RNA5SP390 as a Biomarker
The potential use of RNA5SP390 as a biomarker for disease has significant implications for the development of new diagnostic tests and therapies. RNA5SP390 has been shown to be expressed in a wide range of tissues and cells, including brain, heart, and cancer cells. This suggests that RNA5SP390 may be a useful biomarker for a variety of diseases, including cancer and neurodegenerative disorders.
RNA5SP390 has also been shown to be highly expressed in tissues that are often affected by diseases, such as cancer and neurodegenerative disorders. This suggests that RNA5SP390 may be a useful biomarker for
Protein Name: RNA, 5S Ribosomal Pseudogene 390
The "RNA5SP390 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNA5SP390 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
RNA5SP393 | RNA5SP410 | RNA5SP425 | RNA5SP437 | RNA5SP44 | RNA5SP444 | RNA5SP450 | RNA5SP456 | RNA5SP463 | RNA5SP464 | RNA5SP465 | RNA5SP479 | RNA5SP493 | RNA5SP496 | RNA5SP497 | RNA5SP505 | RNA5SP511 | RNA5SP518 | RNA5SP52 | RNA5SP53 | RNA5SP54 | RNA5SP57 | RNA5SP63 | RNA5SP85 | RNA5SP91 | RNASE1 | RNASE10 | RNASE11 | RNASE11-AS1 | RNASE12 | RNASE13 | RNASE2 | RNASE2CP | RNASE3 | RNASE4 | RNASE6 | RNASE7 | RNASE8 | RNASE9 | RNASEH1 | RNASEH1-DT | RNASEH2A | RNASEH2B | RNASEH2B-AS1 | RNASEH2C | RNASEH2CP1 | RNASEK | RNASEL | RNASET2 | RND1 | RND2 | RND3 | RNF10 | RNF103 | RNF103-CHMP3 | RNF11 | RNF111 | RNF112 | RNF113A | RNF113B | RNF114 | RNF115 | RNF121 | RNF122 | RNF123 | RNF125 | RNF126 | RNF126P1 | RNF128 | RNF13 | RNF130 | RNF133 | RNF135 | RNF138 | RNF138P1 | RNF139 | RNF139-DT | RNF14 | RNF141 | RNF144A | RNF144B | RNF145 | RNF146 | RNF148 | RNF149 | RNF150 | RNF151 | RNF152 | RNF157 | RNF157-AS1 | RNF165 | RNF166 | RNF167 | RNF168 | RNF169 | RNF17 | RNF170 | RNF175 | RNF180 | RNF181
